[PDF][PDF] Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1

P Yi, Q Feng, L Amazit, DM Lonard, SY Tsai, MJ Tsai… - Molecular cell, 2008 - cell.com
P Yi, Q Feng, L Amazit, DM Lonard, SY Tsai, MJ Tsai, BW O'Malley
Molecular cell, 2008cell.com
Summary SRC-3/AIB1 is a steroid receptor coactivator with potent growth-promoting activity,
and its overexpression is sufficient to induce tumorigenesis. Previous studies indicate that
the cellular level of SRC-3 is tightly regulated by both ubiquitin-dependent and ubiquitin-
independent proteasomal degradation pathways. Atypical protein kinase C (aPKC) is
frequently overexpressed in cancers. In the present study, we show that aPKC
phosphorylates and specifically stabilizes SRC-3 in a selective ER-dependent manner. We …
Summary
SRC-3/AIB1 is a steroid receptor coactivator with potent growth-promoting activity, and its overexpression is sufficient to induce tumorigenesis. Previous studies indicate that the cellular level of SRC-3 is tightly regulated by both ubiquitin-dependent and ubiquitin-independent proteasomal degradation pathways. Atypical protein kinase C (aPKC) is frequently overexpressed in cancers. In the present study, we show that aPKC phosphorylates and specifically stabilizes SRC-3 in a selective ER-dependent manner. We further demonstrate that an acidic residue-rich region in SRC-3 is an important determinant for aPKC-mediated phosphorylation and stabilization. The mechanism of the aPKC-mediated stabilization appears due to a decreased interaction between SRC-3 and the C8 subunit of the 20S core proteasome, thus preventing SRC-3 degradation. Our results demonstrate a potent signaling mechanism for regulating SRC-3 levels in cells by coordinate enzymatic inhibition of both ubiquitin-dependent and ubiquitin-independent proteolytic pathways.
cell.com